Episode 64: Genetics, Advocacy, and Big Data in ALS

Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Matthew B. Harms, MD.

Episode 64 of the NeurologyLive Mind Moments podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.

Episode 64, "Genetics, Advocacy, and Big Data in ALS," features an exclusive interview with Matthew B. Harms, MD, associate professor of neurology, Columbia University, and medical consultant and care center director, Muscular Dystrophy Association (MDA). He spoke about the progress that the field has seen in recent years in improving the genetic understanding of amyotrophic lateral sclerosis (ALS) and the role that big data can play in care, as well as shared his perspective on the impact that advocacy efforts have had on these advances.

The stories highlighted in this episode's Neurology News Minute can be found here:

EPISODE BREAKDOWN

2:05 – Major progress in ALS in recent years

4:35 – Key steps forward in genetic testing

7:25 – The understanding of genetics in ALS

9:20 – The role of databases in the care paradigm

11:35 – Neurology News Minute

15:25 – Advocacy's role in the last decade

18:40 – The state of clinical trials for ALS

20:40 – The pipeline of therapies and the future of treatment

24:50 – Importance of continued advocacy for ALS

Click here to subscribe to the Mind Moments podcast. Be sure to leave a rating and review for the show. Thanks for listening!